For cancer patients on immunotherapy, harmful gut bacteria might matter more than helpful ones

Cell research on rare disease finds new link to inflammation
28 February 2022
Number of children living in home with loaded, unlocked firearms unchanged
28 February 2022

For cancer patients on immunotherapy, harmful gut bacteria might matter more than helpful ones

Melanoma patients receiving therapy that helps their immune system kill cancer cells respond to treatment differently depending on the types of microbes in their gut, and new research suggests the microorganisms hindering therapy have more influence than the beneficial ones.

Comments are closed.